Paediatric sepsis survivors are resistant to sepsis‐induced long‐term immune dysfunction

Abstract

AbstractBackground and PurposeSepsis‐surviving adult individuals commonly develop immunosuppression and increased susceptibility to secondary infections, an outcome mediated by the axis IL‐33/ILC2s/M2 macrophages/Tregs. Nonetheless, the long‐term immune consequences of paediatric sepsis are indeterminate. We sought to investigate the role of age in the genesis of immunosuppression following sepsis.Experimental ApproachHere, we compared the frequency of Tregs, the activation of the IL‐33/ILC2s axis in M2 macrophages and the DNA methylation of epithelial lung cells from post‐septic infant and adult mice. Likewise, sepsis‐surviving mice were inoculated intranasally with Pseudomonas aeruginosa or by subcutaneous inoculation of the B16 melanoma cell line. Finally, blood samples from sepsis‐surviving patients were collected and the concentration of IL‐33 and Tregs frequency were assessed.Key ResultsIn contrast to 6‐week‐old mice, 2‐week‐old mice were resistant to secondary infection and did not show impairment in tumour controls upon melanoma challenge. Mechanistically, increased IL‐33 levels, Tregs expansion, and activation of ILC2s and M2‐macrophages were observed in 6‐week‐old but not 2‐week‐old post‐septic mice. Moreover, impaired IL‐33 production in 2‐week‐old post‐septic mice was associated with increased DNA methylation in lung epithelial cells. Notably, IL‐33 treatment boosted the expansion of Tregs and induced immunosuppression in 2‐week‐old mice. Clinically, adults but not paediatric post‐septic patients exhibited higher counts of Tregs and seral IL‐33 levels.Conclusion and ImplicationsThese findings demonstrate a crucial and age‐dependent role for IL‐33 in post‐sepsis immunosuppression. Thus, a better understanding of this process may lead to differential treatments for adult and paediatric sepsis.